Overview

Short Term Low Dose Corticosteroids for Management of Post covid19 Pulmonary Fibrosis

Status:
Completed
Trial end date:
2020-07-30
Target enrollment:
Participant gender:
Summary
A randomized controlled trial to study the efficacy of low dose steroid for 14 days in the treatment of post-covid-19 lung infiltrates
Phase:
N/A
Details
Lead Sponsor:
South Valley University
Treatments:
Prednisone